Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effects of Low Sodium Intake on the Anti-proteinuric Efficacy of Olmesartan in Hypertensive Patients With Albuminuria Through Open-label Randomized Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01552954
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:47.656092+00:00
Published At
2014-12-18T00:00:00+00:00
Record Updated At
2014-12-18
Results Posted At
2014-12-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hypertension", "Chronic Kidney Disease", "Microalbuminuria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-12-18"
protocolSection.identificationModule.nctId
"NCT01552954"
protocolSection.identificationModule.officialTitle
"Effects of Low Sodium Intake on the Anti-proteinuric Efficacy of Olmesartan in Hypertensive Patients With Albuminuria Through Open-label Randomized Trial"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-12-18"

Study condition terms

  • Hypertension (protocolSection.conditionsModule.conditions)
  • Chronic Kidney Disease (protocolSection.conditionsModule.conditions)
  • Microalbuminuria (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.